Iontophoresis Device For Cross-Linking Receives CE Mark

Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management

Monday, March 25, 2013

Ocular Surgery News

Sooft italia has been granted a CE mark for an iontophoresis device to deliver riboflavin to the cornea to treat keratoconus, according to a company news release.

Full Story

What is the most common granulomatous inflammation seen in the eyelid?
1. sarcoidosis
2. seborrheic keratosis
3. chalazion
4. papilloma
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
OPMI LUMERA 700 Surgical Microscope
OPMI LUMERA 700 Incorporating the latest... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Iontophoresis Device For Cross-Linking Receives CE Mark

Comments

Quick Quiz

What is the most common granulomatous inflammation seen in the eyelid?

AdGlare RMR Ad

Featured Products

CareCloud Charts For Ophthalmology

OPMI LUMERA 700 Surgical Microscope

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2